Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEterna Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Eterna Therapeutics Inc. Earnings Date And Information
Eterna Therapeutics Inc. last posted its earnings results on Monday, November 14th, 2022. The company reported $-2.49 earnings per share for the quarter, missing analysts' consensus estimates of $-2.2 by $0.29. The company had revenue of 487,000 for the quarter and had revenue of 68,000 for the year. Eterna Therapeutics Inc. has generated $-4 earnings per share over the last year ($-4.08 diluted earnings per share) and currently has a price-to-earnings ratio of -0.05. Eterna Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
Eterna Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$4.92 | $487,000 | $487,000 | ||
| 08/13/2024 | Q2 2024 | -$1.02 | $47,000 | $47,000 | ||
| 05/14/2024 | Q1 2024 | -$1.23 | $47,000 | |||
| 03/18/2024 | Q4 2023 | -$1.14 | $17,000 | |||
| 11/13/2023 | Q3 2023 | -$1.03 | $51,000 | |||
| 08/11/2023 | Q2 2023 | -$0.85 | $0 | |||
| 05/11/2023 | Q1 2023 | -$1.06 | $0 | |||
| 03/20/2023 | Q4 2022 | -$1.02 | $0 | |||
| 11/14/2022 | Q3 2022 | -$2.20 | -$2.49 | -0.29 | $0 | |
| 08/11/2022 | Q2 2022 | -$2.60 | $2.41 | 5.01 | $0 | |
| 06/30/2022 | Q1 2022 | -$2.80 | -$4.65 | -1.85 | $0 | |
| 06/30/2022 | Q4 2021 | -$2.80 | -$3.25 | -0.45 | $0 | |
| 11/12/2021 | Q3 2021 | -$34.05 | $0 | |||
| 06/29/2021 | Q2 2021 | -$4.75 | $0 | |||
| 03/30/2021 | Q1 2021 | -$12.74 | $0 | |||
| 12/30/2020 | Q4 2020 | -$1.60 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.97 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.98 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.49 | $0 |
Eterna Therapeutics Inc. Earnings: FAQ's
When is Eterna Therapeutics Inc.'s earnings date?
Eterna Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
How can I listen to Eterna Therapeutics Inc.'s earnings conference
call?
The conference call for Eterna Therapeutics Inc.'s latest earnings report can be listened to online.
How can I read Eterna Therapeutics Inc.'s conference call transcript?
The conference call transcript for Eterna Therapeutics Inc.'s latest earnings report can be read online.
How much revenue does Eterna Therapeutics Inc. generate each year?
Eterna Therapeutics Inc. (:ERNA) has a recorded annual revenue of $68,000.
How much profit does Eterna Therapeutics Inc. generate each year?
Eterna Therapeutics Inc. (:ERNA) has a recorded net income of $68,000. Eterna Therapeutics Inc. has generated $-4.08 earnings per share over the last four quarters.
What is Eterna Therapeutics Inc.'s price-to-earnings ratio?
Eterna Therapeutics Inc. (:ERNA) has a price-to-earnings ratio of -0.05 and price/earnings-to-growth ratio is 0.